London, UK (PRWEB UK) 7 September 2013
In anticipation of the rainy season, teams from Médecins Sans Frontières/Doctors Without Borders (MSF) in Niger are distributing medicine that will prevent malaria, it was announced August 19th. The rainy season increases malaria risk in Niger, since the mosquitoes breed in stagnant water. This is the first time that SMC has been used in Niger. However, Anja Wolz, MSF’s medical coordinator in Niger, commented, “SMC is not a miracle cure. It allows us to reduce the mortality rate and the number of cases of malaria in countries where there is limited access to care. But the top priority is to continue to increase the provision of mosquito nets and insecticidal spray, as well as diagnosing and treating cases of malaria.” (http://www.msf.org.uk/article/niger-more-180000-children-benefit-new-anti-malaria-treatment)
With this in mind, Yourwellness Magazine investigated a new potential treatment for malaria. According to Yourwellness Magazine, “In the on-going battle with viruses and diseases, technology is our ultimate ally. Whether it is improving methods of surgery, finding new forms of treatment or just allowing scientists to go further in their studies, technology is making life a safer place to be, every single day. And today is no different as a team of scientists have announced that they may have found a new way to combat malaria.” (http://www.yourwellness.com/2013/02/3d-study-could-provide-new-treatment-for-malaria/#sthash.IrW79F42.dpuf)
Yourwellness Magazine explained that malaria is one of the most devastating infectious diseases in the world, killing over a million people every year. It also newly infects 250 million individuals per year. Yourwellness Magazine noted that many of those people are infected when they are bitten by mosquitoes carrying the Plasmodium parasite, and these mosquitoes are becoming more and more resistant to current drugs. Yourwellness Magazine commented that a new technique called electron microscopy allows scientists to look at the 3D crystal structure of the assembly from individual proteins, which serves as a good starting point for developing specific inhibitors that could target active enzyme sites, and, if successful, may one day lead to new treatments.
To find out more, visit the gateway to living well at http://www.yourwellness.com.